Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC.INO · Entity 6589 | Director | May 11, 2019 | May 13, 2019 |
| KOPIN CORPKOPN · Entity 5134 | Director | December 07, 2021 | December 08, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INOVIO PHARMACEUTICALS, INC.
Report date May 11, 2019 · Filed May 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 168,130 |
Reported balance
After 2019-05-11 transaction · row 1
1 source rowRow 1 · 2019-05-11 · Exercise / conversion · Acquired 8,170 · Balance 168,130 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-05-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-05-11 · Exercise / conversion · Disposed 8,170 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. |
| Common StockSEC Table I · non-derivative | IndirectBy Morton Collins IRA account | 50,000 |
Reported balance
Holding disclosure · report date 2019-05-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse IRA account | 6,650 |
Reported balance
Holding disclosure · report date 2019-05-11 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,650 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 6,450 |
Reported balance
Holding disclosure · report date 2019-05-11 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,450 |
| Common StockSEC Table I · non-derivative | IndirectBy Collins Children's Trust | 64,750 |
Reported balance
Holding disclosure · report date 2019-05-11 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 64,750 |
| Common StockSEC Table I · non-derivative | IndirectThe Collins Family Foundation Trust | 4,500 |
Reported balance
Holding disclosure · report date 2019-05-11 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 4,500 |
| Common StockSEC Table I · non-derivative | IndirectBy Collin Grandchildren's Trust | 64,750 |
Reported balance
Holding disclosure · report date 2019-05-11 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 64,750 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019.
KOPIN CORP
Report date December 07, 2021 · Filed December 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 120,000 |
Reported balance
After 2021-12-07 transaction · row 1
1 source rowRow 1 · 2021-12-07 · Sale · Disposed 20,000 · Balance 120,000 |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 44,500 |
Reported balance
Holding disclosure · report date 2021-12-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 44,500 F1: These shares are held in a trust for the benefit of the reporting person's grandchildren. The reporting person's wife is a co-trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are held in a trust for the benefit of the reporting person's grandchildren. The reporting person's wife is a co-trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2021 Filed Dec 8, 2021 21:15 UTC | KOPIN CORP KOPN · Entity 5134 | SaleCommon Stock | 20,000 | $5.05 | $101,034.00 |
DisclosureSEC source: 0001493152-21-030826 · ownership.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Read SEC document |
| May 21, 2021 Filed May 27, 2021 20:50 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-013082 · ownership.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 F1 · kind: The equity award vests on the first anniversary of the date of grant (05/26/22). Read SEC document |
| February 16, 2021 Filed Feb 23, 2021 22:02 UTC | KOPIN CORP KOPN · Entity 5134 | SaleCommon Stock | 44,000 | $12.48 | $549,120.00 |
DisclosureSEC source: 0001493152-21-004614 · ownership.xml · nonDerivative · entry 5 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 44,500 F4 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's grandchildren. The reporting person's wife is a co-trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purpose. Read SEC document |
| February 16, 2021 Filed Feb 23, 2021 22:02 UTC | KOPIN CORP KOPN · Entity 5134 | SaleCommon Stock | 44,500 | $12.70 | $565,150.00 |
DisclosureSEC source: 0001493152-21-004614 · ownership.xml · nonDerivative · entry 4 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F3 · ownership.nature: These shares were held in a trust for the benefit of the reporting person's children. The reporting person's wife is a co-trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purpose. Read SEC document |
| February 12, 2021 Filed Feb 23, 2021 22:02 UTC | KOPIN CORP KOPN · Entity 5134 | SaleCommon Stock | 44,000 | $10.33 | $454,520.00 |
DisclosureSEC source: 0001493152-21-004614 · ownership.xml · nonDerivative · entry 3 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 44,500 F3 · ownership.nature: These shares were held in a trust for the benefit of the reporting person's children. The reporting person's wife is a co-trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purpose. Read SEC document |
| February 11, 2021 Filed Feb 23, 2021 22:02 UTC | KOPIN CORP KOPN · Entity 5134 | SaleCommon Stock | 11,500 | $10.02 | $115,230.00 |
DisclosureSEC source: 0001493152-21-004614 · ownership.xml · nonDerivative · entry 2 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F2 · ownership.nature: These shares were held by the reporting person's wife. Read SEC document |
| February 11, 2021 Filed Feb 23, 2021 22:02 UTC | KOPIN CORP KOPN · Entity 5134 | SaleCommon Stock | 21,000 | $10.03 | $210,630.00 |
DisclosureSEC source: 0001493152-21-004614 · ownership.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · ownership.nature: These shares were held by the reporting person's wife in her IRA. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:10 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-010396 · ownership.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 F1 · kind: The equity award vests on the first anniversary of the date of grant (06/01/21). Read SEC document |
| May 21, 2019 Filed May 21, 2019 20:07 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-19-000062 · wf-form4_155846925207017.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 F1 · kind: The equity award vests on the first anniversary of the date of grant (5/21/19). Read SEC document |
| May 11, 2019 Filed May 13, 2019 19:56 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionRestricted Stock Unit · Derivative | 8,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-19-000037 · wf-form4_155777740114592.xml · derivative · entry 8 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. Read SEC document |
| May 11, 2019 Filed May 13, 2019 19:56 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 8,170 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-19-000037 · wf-form4_155777740114592.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. Read SEC document |
| May 08, 2019 Filed May 9, 2019 22:06 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantRestricted Stock Unit · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-19-000034 · wf-form4_155743955429950.xml · derivative · entry 2 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,013 Underlying: Common Stock · 8,013 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020. F1 · shares: This grant was made pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020. Read SEC document |
| May 08, 2019 Filed May 9, 2019 22:06 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantCommon Stock Options · Derivative | 12,500 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001055726-19-000034 · wf-form4_155743955429950.xml · derivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-05-08 F1 · shares: This grant was made pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest with respect to 100% of the shares on May 8, 2020. Read SEC document |
| May 12, 2018 Filed May 14, 2018 22:06 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionRestricted Stock Unit · Derivative | 7,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-18-000030 · wf-form4_152633558486739.xml · derivative · entry 10 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,669 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. Read SEC document |
| May 12, 2018 Filed May 14, 2018 22:06 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 7,669 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-18-000030 · wf-form4_152633558486739.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. Read SEC document |
| May 11, 2018 Filed May 14, 2018 22:06 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantRestricted Stock Unit · Derivative | 8,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-18-000030 · wf-form4_152633558486739.xml · derivative · entry 9 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,170 Underlying: Common Stock · 8,170 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019. Read SEC document |
| May 11, 2018 Filed May 14, 2018 22:06 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantCommon Stock Option · Derivative | 12,500 | $0.00 Strike: $4.56 | $0.00 |
DisclosureSEC source: 0001055726-18-000030 · wf-form4_152633558486739.xml · derivative · entry 8 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2028-05-11 F2 · derivative.exercise_date: Options to vest 100% on May 11, 2019. Read SEC document |
| May 09, 2018 Filed Jul 5, 2018 12:00 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-18-000030 · wf-form4_153079199231396.xml · nonDerivative · entry 4 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 88,500 F4 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's grandchildren. The reporting person's wife is a co-trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2018 Filed Jul 5, 2018 12:00 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-18-000030 · wf-form4_153079199231396.xml · nonDerivative · entry 3 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 88,500 F3 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's children. The reporting person's wife is a co-trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2018 Filed Jul 5, 2018 12:00 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-18-000030 · wf-form4_153079199231396.xml · nonDerivative · entry 2 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 31,500 F2 · ownership.nature: These shares are held by the reporting person's wife in her IRA Read SEC document |
| May 09, 2018 Filed Jul 5, 2018 12:00 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-18-000030 · wf-form4_153079199231396.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 F1 · kind: The equity award vests on the first anniversary of the date of grant (5/9/19) Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 13:57 UTC Amendment | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 31,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-17-000043 · wf-form4a_149641182871983.xml · nonDerivative · entry 2 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 31,500 F1 · ownership.nature: These shares are held by the reporting person's wife in her IRA. On May 18, 2016 the reporting person filed a Form 4 reporting the purchase of 31,500 shares in Column 4, the purchase was incorrectly shown in Column 5 as 31,000. This Form 4 corrects column 5. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 13:57 UTC Amendment | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-17-000043 · wf-form4a_149641182871983.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 13:56 UTC | KOPIN CORP KOPN · Entity 5134 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-17-000041 · wf-form4_149641178716400.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · kind: The equity award vests on the first anniversary of the date of the grant (05/31/18). Read SEC document |
| May 13, 2017 Filed May 15, 2017 21:03 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionRestricted Stock Unit · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-17-000026 · wf-form4_149488220755604.xml · derivative · entry 10 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. Read SEC document |
| May 13, 2017 Filed May 15, 2017 21:03 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-17-000026 · wf-form4_149488220755604.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. Read SEC document |
| May 12, 2017 Filed May 15, 2017 21:03 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantCommon Stock Options · Derivative | 12,500 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001055726-17-000026 · wf-form4_149488220755604.xml · derivative · entry 9 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-12 F3 · derivative.exercise_date: Options to vest 100% on May 12, 2018. Read SEC document |
| May 12, 2017 Filed May 15, 2017 21:03 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantRestricted Stock Unit · Derivative | 7,669 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-17-000026 · wf-form4_149488220755604.xml · derivative · entry 8 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,669 Underlying: Common Stock · 7,669 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. Read SEC document |
| March 27, 2017 Filed Mar 28, 2017 18:43 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | PurchaseCommon Stock | 21,300 | $6.25 | $133,188.90 |
DisclosureSEC source: 0001055726-17-000017 · wf-form4_149072659693921.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Morton Collins IRA account Disclosed balance after: 50,000 Read SEC document |
| November 02, 2006 Filed Apr 12, 2019 20:04 UTC | KOPIN CORP KOPN · Entity 5134 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-19-000048 · wf-form4_155509945069489.xml · nonDerivative · entry 2 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Wife Disclosed balance after: 1,000 Read SEC document |
| November 02, 2006 Filed Apr 12, 2019 20:04 UTC | KOPIN CORP KOPN · Entity 5134 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000771266-19-000048 · wf-form4_155509945069489.xml · nonDerivative · entry 1 COLLINS MORTON · CIK 0001238716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.